Defining treatment sensitivities in Myc related PDAC Subtypes
Ontology highlight
ABSTRACT: Part1: Epigenetic Drug Screening Defines a PRMT5 Inhibitor Sensitive Pancreatic Cancer Subtype; Part2: Indirect targeting of MYC sensitizes pancreatic cancer cellsto mechanistic target of rapamycin (mTOR) inhibition
PROVIDER: PRJEB43040 | ENA |
REPOSITORIES: ENA
ACCESS DATA